Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Analogs of N'-hydroxy-N-(4H,5H-naphtho[1,2-d]thiazol-2-yl)methanimidamide inhibit Mycobacterium tuberculosis methionine aminopeptidases.

Bhat S, Olaleye O, Meyer KJ, Shi W, Zhang Y, Liu JO.

Bioorg Med Chem. 2012 Jul 15;20(14):4507-13. doi: 10.1016/j.bmc.2012.05.022. Epub 2012 May 17.

2.

Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets.

Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR, Liu JO.

Chem Biol. 2010 Jan 29;17(1):86-97. doi: 10.1016/j.chembiol.2009.12.014.

3.

Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis.

Olaleye O, Raghunand TR, Bhat S, Chong C, Gu P, Zhou J, Zhang Y, Bishai WR, Liu JO.

Tuberculosis (Edinb). 2011 Dec;91 Suppl 1:S61-5. doi: 10.1016/j.tube.2011.10.012. Epub 2011 Nov 23.

PMID:
22115541
4.

Inhibition of Mycobacterium tuberculosis methionine aminopeptidases by bengamide derivatives.

Lu JP, Yuan XH, Yuan H, Wang WL, Wan B, Franzblau SG, Ye QZ.

ChemMedChem. 2011 Jun 6;6(6):1041-8. doi: 10.1002/cmdc.201100003. Epub 2011 Apr 4.

5.

Structural analysis of inhibition of Mycobacterium tuberculosis methionine aminopeptidase by bengamide derivatives.

Lu JP, Yuan XH, Ye QZ.

Eur J Med Chem. 2012 Jan;47(1):479-84. doi: 10.1016/j.ejmech.2011.11.017. Epub 2011 Nov 17.

6.

Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.

Alegaon SG, Alagawadi KR, Dadwe DH.

Drug Res (Stuttg). 2014 Oct;64(10):553-8. doi: 10.1055/s-0033-1363976. Epub 2014 Jan 20.

PMID:
24446205
7.

Catalysis and inhibition of Mycobacterium tuberculosis methionine aminopeptidase.

Lu JP, Chai SC, Ye QZ.

J Med Chem. 2010 Feb 11;53(3):1329-37. doi: 10.1021/jm901624n.

8.

Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.

Krátký M, Vinšová J, Novotná E, Mandíková J, Wsól V, Trejtnar F, Ulmann V, Stolaříková J, Fernandes S, Bhat S, Liu JO.

Tuberculosis (Edinb). 2012 Sep;92(5):434-9. doi: 10.1016/j.tube.2012.06.001. Epub 2012 Jul 4.

PMID:
22765970
9.

Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.

Altimari JM, Hockey SC, Boshoff HI, Sajid A, Henderson LC.

ChemMedChem. 2015 May;10(5):787-91. doi: 10.1002/cmdc.201500051. Epub 2015 Mar 18.

PMID:
25788466
10.

Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors.

Salve PS, Alegaon SG, Sriram D.

Bioorg Med Chem Lett. 2017 Apr 15;27(8):1859-1866. doi: 10.1016/j.bmcl.2017.02.031. Epub 2017 Feb 17.

PMID:
28274627
11.

Expression and characterization of Mycobacterium tuberculosis methionine aminopeptidase type 1a.

Lu JP, Ye QZ.

Bioorg Med Chem Lett. 2010 May 1;20(9):2776-9. doi: 10.1016/j.bmcl.2010.03.067. Epub 2010 Mar 19.

12.

5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.

Matyugina E, Novikov M, Babkov D, Ozerov A, Chernousova L, Andreevskaya S, Smirnova T, Karpenko I, Chizhov A, Murthu P, Lutz S, Kochetkov S, Seley-Radtke KL, Khandazhinskaya AL.

Chem Biol Drug Des. 2015 Dec;86(6):1387-96. doi: 10.1111/cbdd.12603. Epub 2015 Jul 14. Erratum in: Chem Biol Drug Des. 2016 Feb;87(2):312.

PMID:
26061192
13.

Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.

Baig IA, Moon JY, Lee SC, Ryoo SW, Yoon MY.

Biochim Biophys Acta. 2015 Oct;1854(10 Pt A):1338-50. doi: 10.1016/j.bbapap.2015.05.003. Epub 2015 May 16.

PMID:
25988243
14.

Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.

Chandran M, Renuka J, Sridevi JP, Pedgaonkar GS, Asmitha V, Yogeeswari P, Sriram D.

Int J Mycobacteriol. 2015 Jun;4(2):104-15. doi: 10.1016/j.ijmyco.2015.02.002. Epub 2015 Mar 26.

15.

Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.

Castagnolo D, Manetti F, Radi M, Bechi B, Pagano M, De Logu A, Meleddu R, Saddi M, Botta M.

Bioorg Med Chem. 2009 Aug 1;17(15):5716-21. doi: 10.1016/j.bmc.2009.05.058. Epub 2009 May 29.

PMID:
19581099
16.

Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.

Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.

Bioorg Med Chem. 2014 Aug 1;22(15):4223-32. doi: 10.1016/j.bmc.2014.05.038. Epub 2014 May 23.

PMID:
24953948
17.

Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.

Shiradkar MR, Murahari KK, Gangadasu HR, Suresh T, Kalyan CA, Panchal D, Kaur R, Burange P, Ghogare J, Mokale V, Raut M.

Bioorg Med Chem. 2007 Jun 15;15(12):3997-4008. Epub 2007 Apr 6.

PMID:
17442576
18.

Amino-terminal extension present in the methionine aminopeptidase type 1c of Mycobacterium tuberculosis is indispensible for its activity.

Kanudia P, Mittal M, Kumaran S, Chakraborti PK.

BMC Biochem. 2011 Jul 5;12:35. doi: 10.1186/1471-2091-12-35.

19.

Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis.

Meissner A, Boshoff HI, Vasan M, Duckworth BP, Barry CE 3rd, Aldrich CC.

Bioorg Med Chem. 2013 Nov 1;21(21):6385-97. doi: 10.1016/j.bmc.2013.08.048. Epub 2013 Sep 3.

20.

Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.

Naidu KM, Nagesh HN, Singh M, Sriram D, Yogeeswari P, Gowri Chandra Sekhar KV.

Eur J Med Chem. 2015 Mar 6;92:415-26. doi: 10.1016/j.ejmech.2015.01.013. Epub 2015 Jan 9.

PMID:
25590862

Supplemental Content

Support Center